Inventor
TIANAN FANG
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds37%
A61KPreparations for medical, dental or toiletry purposes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
PatentTitleYear
12,428,421Pyrimidinones as factor XIA inhibitors202512,404,274Macrocycles as factor xia inhibitors2025RE049352Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists202311,352,345Cyclohexyl acid pyrazole azoles as LPA antagonists202211,319,315Cyclohexyl acid triazole azoles as LPA antagonists202211,267,800Cyclohexyl acid triazole azines as LPA antagonists202211,136,327Macrocycles as factor XIA inhibitors2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to BRISTOL MYERS SQUIBB CO (7)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 7 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2025 |